Fee-for-service cores for Investigational New Drug enabling studies



Similar documents
Stem Cells and Inner Ear Cell Regeneration. Stefan Heller Stanford University School of Medicine

UC Davis Institute for Regenerative Cures A facility supported by the California Institute for Regenerative Medicine

STEM CELL FACTS. The ISSCR is an independent, nonproft organization providing a global forum for stem cell research and regenerative medicine.

Roche Position on Human Stem Cells

International Stem Cell Registry

5 Frequently Asked Questions About Adult Stem Cell Research

Please visit this site for the current GESCR procedures info:

The ethics of stem cell research and treatment

Stem Cell Quick Guide: Stem Cell Basics

Chapter 16 Reproductive Technology, Gene Therapy, and Stem Cells (modified)

Cord derived MSC-Like Placenta derived Membranes- Matrix- Cells- MSC-like,

A Genetic Analysis of Rheumatoid Arthritis

Valentina Gualato, Ph.D. Process Development Scientist

Disclosure. Gene Therapy. Transfer of genes into cells Expression of transferred genes

PART I. SECTION 1. The legislature finds that an estimated. 128,000,000 Americans suffer from the crippling economic and

exactly. The need for efficiency in developing effective new therapeutics has never been greater.

Stem cells and motor neurone disease

Umbilical Cord Blood Stem Cells Current Status & Future Potential

Stem Cell-based Therapies and FDA Regulations

HUMAN STEM CELLS DERIVED FROM CORD BLOOD REDUCES THE SIZE OF PANCREATIC TUMOR IN SCID MICE.

AAGPs TM Anti-Aging Glyco Peptides. Enhancing Cell, Tissue and Organ Integrity Molecular and biological attributes of lead AAGP molecule

STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE

The Therapeutic Potential of Human Umbilical Cord Blood Transplantation for Neonatal Hypoxic-Ischemic Brain Injury and Ischemic Stroke

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

Top Ten Things to Know About Stem Cell Treatments

How To Expand Hematopoietic Stem Cells

STEM CELL FELLOWSHIP

Andra E. Miller, Ph.D PROFESSIONAL EXPERIENCE:

San Diego Stem Cell Treatment Center Frequently Asked Questions

It s not something you want to think about, but it s something you want to prepare for.

Luca Romagnoli, Ph.D. Business Development Manager

Patient Handbook on Stem Cell Therapies

Stem cells possess 2 main characteristics: Sources of pluripotent stem cells: -Long-term self renewal. -The inner cell mass of the blastocyst.

Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC

Discover the Possibilities Born With Your Baby

Stem Cells: Scientific Progress and Future Research Directions

Biotechnology. Srivatsan Kidambi, Ph.D.

Guidance For Research Involving Human Embryonic Stem Cells, Germ Cells, And Cells Obtained From Cord Blood

tem ells /background /information Stem cell research Copyright 2007 MRC Centre for Regenerative Medicine, Institute for Stem Cell Research

Hematopoiesis i starts from. HPC differentiates t to sequentially more mature. HPC circulate in very low

What are Stem Cells? How can they be used in medicine?

15 Stem Cell Research

Stem Cells Market Trends based on Primary Industry Analysis

Stem Cell Information

Cord Blood Bank Business Plan

BIOTECHNOLOGY OPERATIONS

One of the most important recent developments in cancer treatment has been the ability to harvest stem

07 SB148/FA/1 A BILL TO BE ENTITLED AN ACT

cord blood saves lives...

Policy statement. Stem cell research

How To Treat Leukaemia With Cord Blood Stem Cell

your complete stem cell bank

Reprogramming, Screening and Validation of ipscs and Terminally Differentiated Cells using the qbiomarker PCR Array System

DEVELOPING AND TESTING RETRIEVABLE DEVICES AND SCAFFOLDS FOR BETA CELL REPLACEMENT THERAPIES

guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research

The Prospect of Stem Cell Therapy in Multiple Sclerosis. Multiple sclerosis is a multifocal inflammatory disease of the central

2.1.2 Characterization of antiviral effect of cytokine expression on HBV replication in transduced mouse hepatocytes line

The Types of stem cells: Totipotent Pluripotent Multipotent

a message to my child Why we saved your stem cells with Stembanc when you were born.

Introducing stem cells Stem cells in the news

COLUMBIA UNIVERSITY POLICY ON THE CONDUCT OF RESEARCH WITH HUMAN EMBRYOS AND HUMAN EMBRYONIC STEM CELLS*

Basic Overview of Preclinical Toxicology Animal Models

Equine Stem Cells. Sources, Processing, Expansion, Storage and Shipping

RITMIR024 - STEM CELL RESEARCH IN CARDIOLOGY

Stem Cell Therapy Applications in pediatric neurology

47/CNECV/05 STEM CELL RESEARCH

Stem cell research and Parkinson's

Biopharmaceutical Process Evaluated for Viral Clearance

Do you have anything to add? If so, I d love to hear from you! Jessica Robinson Conference Manager Life

[DOCKET NO.96N-0002] DRAFT

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Geniron. Custom Antibody Services. Serum services Antibody Monoclonal. Purification Antibody Mono Y Genetic Immunization Genbody Polyclonal Antibody

Transmedcon Ahmedabad, Gujarat November 14-16, 2014

FGF-1 as Cosmetic Supplement

the future in your hands imagine

Embryonic & and induced pluripotent Stem Cells. May 2010 Dipl. Biol. Dr. Kurt Pfannkuche

Bio-manufacturing of antigens, antibodies and bioresearch materials

DNA Fingerprinting. Unless they are identical twins, individuals have unique DNA

Current Issues in Stem Cell Technologies. Lance D. Trainor, MD OneBlood, Inc.

Achieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013

An Introduction to Stem Cell Biology. Michael L. Shelanski, MD,PhD Professor of Pathology and Cell Biology Columbia University

Stem Cell Basics. About this document. I. Introduction: What are stem cells, and why are they important?

Transcription:

UC DAVIS INSTITUTE FOR REGENERATIVE CURES Fee-for-service cores for Investigational New Drug enabling studies

Pipeline pathway at UC Davis Institute for Regenerative Cures Basic Research Proof of Concept Development Candidate Filing IND Clinical Trials Showing that an idea for a therapy has potential Showing that a specific cell or molecule is effective in an animal or test tube Gathering data to show that the cell or molecule is safe to test in humans

Reasonable rates, flexible scheduling, and a welcoming environment Stem Cell Program Core Facilities and Resources UC Davis Institute for Regenerative Cures offers leadingedge research services for Investigational New Drug (IND) development. Located in Sacramento and anchored by Northern California s largest academic Good Manufacturing Practice facility, the institute s fee-for-service cores and support services include pre-clinical transplantation assays in immune deficient mouse models, as well as an ability to scale-up manufacturing processes for novel cell and gene therapies. From bench to bedside, UC Davis can meet research needs with affordable services for investigators, including external academic and industry partners. n Stem cell core n Vector core n Karyotyping core n Vivarium n Mouse cores n Regulatory core n Umbilical cord blood n Good Manufacturing Practice facility n Quality control testing laboratory

Stem Cell Core With interest increasing in induced pluripotent stem cell (ipsc) cultures and embryonic stem cell lines, the Stem Cell Core can generate pluripotent lines from patient fibroblasts or other sources, using state-of-the art technology. The resulting ipsc lines can be differentiated into the tissue of choice that carries a patient s genes. Successful projects in this core have generated patient-specific neurons that enabled disease-in-a-dish testing of potential therapeutics. Mesenchymal stem cells and umbilical cord blood units are also available for adult stem cell research. contact: Whitney Cary, wcary@ucdavis.edu Vector Core This centralized service features the development and production of viral vectors necessary for gene transfer in research experiments and pre-clinical studies. Expert staff can help investigators plan and develop vectors that fit with individual project requirements. The Vector Core also enables the design and manufacture of novel vectors and purified recombinant retrovirus and lentivirus. Quality control testing includes vector titering and replication-competent retrovirus and lentivirus assays. contact: Karen Pepper, kpepper@ucdavis.edu Karyotyping Core Karyotyping core services enable stability monitoring for human embryonic stem cells, induced pluripotent stem cell lines and mesenchymal stem cells, as well as porcine, murine and rat cell lines. contact: Catherine Nacey, 916-703-9300

Vivarium The institute houses a pathogen-free barrier facility that allows for the breeding of specialized transgenic- and immunedeficient mouse strains and a full range of related services. It consists of approximately 10,500 square feet of shower-in, disease-free housing for experimental mice, along with 14 holding/procedure rooms. Resources within the vivarium include an animal irradiator for transplantation procedures, stereotactic equipment for brain injections, anesthesia machines, behavioral testing rooms, and connection to a variety of stem cell imaging modalities through CMGI. contact: Jan Nolta, janolta@ucdavis.edu or Karyn Tschida, 916-703-9300 Mouse Core (immune-deficient) The immune-deficient mouse core performs procedures on NOD/SCID, NOD/SCID/ B2M null, NOG/Rag -/- and NOD/ SCID/ IL2Rg (gamma chain)-/- mice. Induced pluripotent stem cell lines generated for investigators can be tested for pluripotentiality (teratoma formation), a hallmark of the induction process. The core offers rule-out-tumorigenicity testing for mesenchymal stem/stromal cell batches, before and after transduction, at varying multiplicities of infection. Implanted animals are housed in a clean barrier facility (3 or 6 months) and then sent to the UC Davis Comparative Pathology Laboratory for a full tissue toxicity workup and report in support of IND submissions. contact: Jeannine McGee, jlmcgee@ucdavis.edu for rates and availability Mouse Core (humanized) The mouse core also offers humanization of newborn immunedeficient mice using a variety of strains and cell sources. Additional models of stem cell and behavioral testing are available. Fee-for-service rates are available. contact: Geralyn Annett, gmannett@ucdavis.edu

Regulatory Core On a case-by-case basis, the Institute for Regenerative Cures partners with teams of investigators to assist with the development of pre-ind and IND applications to the U.S. Food and Drug Administration. Institute staff has exceptional skill and experience with gene-modified adult stem cells. Hourly consultation rates are available. contact: William (Bill) Gruenloh, wjgruenloh@ucdavis.edu Umbilical Cord Blood Investigators needing umbilical cord blood units for research now have a convenient source. California s Umbilical Cord Blood Collection Program is managed through the Stem Cell Program at UC Davis. Collection teams gather cord blood units from various hospitals throughout California. Research-grade units are released to qualified researchers at cost. These high-quality units are less than 24 hours old and no less than 70 ml total volume. Same-day and next-day pickups, as well as overnight delivery, are available. The collection program is state funded, collecting cord blood from volunteer donors to help build up the nation s public cord blood registry for life-saving transplants. Cord blood units that fail to meet the strict criteria for public banking are available for research purposes. contact: Christine Posey, ccposey@ucdavis.edu or 844-734-CORD

Good Manufacturing Practice Facility UC Davis Good Manufacturing Practice facility in Sacramento features six manufacturing rooms with Class 10,000, multiuse cleanroom capabilities. It also offers an associated product scale-up and testing lab. Unique features include a GMP-grade FACS sorter, switchable positive-negative room pressurization for gene therapy vector manufacturing, and a hot cell for clinical grade PET reagent manufacturing. This state-of-the-art facility currently manufactures products for university investigators as well as other academic and industry partners. Reasonable hourly rates make it an ideal resource for both campus and external investigators. contact: Gerhard Bauer, gbauer@ucdavis.edu or 916-703-9305 Quality Control Testing Laboratory Quality Control and Quality Assurance form the foundation of UC Davis Institute for Regenerative Cures. The institute teams are experienced and skilled in every aspect of the QC/QA process. Standard operating procedures form the operational foundation for the Good Manufacturing Practice facility. The lab s Quality Control group is responsible for ensuring quality at every level of manufacturing and overseeing product-release testing. The Quality Assurance team is the final authority for guaranteeing that tests and manufacturing processes are performed to prescribed specifications. Standard operating procedures are in place for all release tests, and all tests are controlled as specified. Certificates of Analysis are generated for final products, and the Quality Assurance group is responsible for the release of that product. Only when all certificates are in place and the release criteria are met can products be released. The lab also offers Sysmex instrumentation for progenitor cell enumeration (for clinical transplantation and cord blood banking units). contact: Jon Walker, jonwalker@ucdavis.edu

Stem Cell Program Contacts Jan A. Nolta, Ph.D., Director janolta@ucdavis.edu 916-703-9300 Geralyn Annett, C.L.S, Clinical Research Director gmannett@ucdavis.edu 916-703-9318 Delia Roberts, Manager daroberts@ucdavis.edu 916-703-9311 UC Davis Institute for Regenerative Cures healthsystem.ucdavis.edu/stemcellresearch 14-0181 (4/15)